Abhas Surgicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.52 M
- Revenue Growth 17.76%
- Profit Growth 6.62%
- Ebitda 13.17%
- Net Worth 74.10%
- Total Assets 56.76%
About Abhas Surgicals
Abhas Surgicals Private Limited (ASPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 August 2018 (Six years and five months 29 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.52 M.
Astha Bhatnagar and Abhay Singh serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33209DL2018PTC337908
- Company No.
337908
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Aug 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Abhas Surgicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Astha Bhatnagar  | Director | 28-Aug-2018 | Current |
| Abhay Singh | Director | 28-Aug-2018 | Current |
Financial Performance of Abhas Surgicals.
Abhas Surgicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.76% increase. The company also saw a slight improvement in profitability, with a 6.62% increase in profit. The company's net worth Soared by an impressive increase of 74.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abhas Surgicals?
In 2023, Abhas Surgicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cosmed Surgicals Private LimitedAstha Bhatnagar and Abhay Singh are mutual person
Charges (Loans)
₹8.52 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.65 Cr
- Axis Bank Limited : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jun 2024 | Axis Bank Limited | ₹2.02 M | Open |
| 16 Feb 2024 | Others | ₹6.00 M | Open |
| 11 Jun 2021 | Others | ₹0.50 M | Open |
How Many Employees Work at Abhas Surgicals?
Unlock and access historical data on people associated with Abhas Surgicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abhas Surgicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abhas Surgicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
